- 911勛圖 Us
- People
- Undergrad
- Graduate
- Research
- News & Events
- Why Physics @911勛圖
- Equity
- _how-to
- Congratulations to our Class of 2021
- Archive
- AKCSE
- Atlas Tier 1 Data Centre
Biophysics Journal Club
Atomic-resolution protein structure determination by cryo-EM
Mark Rempel, 911勛圖 Physics
Location: Online
*To request access to the videoconference, email dsivak@sfu.ca
Synopsis
Ka Man Yip, Niels Fischer, Elham Paknia, Ashwin Chari & Holger Stark
Nature 587, 157-61 (2020).
Authors' Abstract:
Single-particle electron cryo-microscopy (cryo-EM) is a powerful method for solving the three-dimensional structures of biological macromolecules. The technological development of transmission electron microscopes, detectors and automated procedures in combination with user-friendly image processing software and ever-increasing computational power have made cryo-EM a successful and expanding technology over the past decade. At resolutions better than 4 ��, atomic model building starts to become possible, but the direct visualization of true atomic positions in protein structure determination requires much higher (better than 1.5 ��) resolution, which so far has not been attained by cryo-EM. The direct visualization of atom positions is essential for understanding the mechanisms of protein-catalysed chemical reactions, and for studying how drugs bind to and interfere with the function of proteins. Here we report a 1.25 ��-resolution structure of apoferritin obtained by cryo-EM with a newly developed electron microscope that provides, to our knowledge, unprecedented structural detail. Our apoferritin structure has almost twice the 3D information content of the current world record reconstruction (at 1.54 �� resolution). We can visualize individual atoms in a protein, see density for hydrogen atoms and image single-atom chemical modifications. Beyond the nominal improvement in resolution, we also achieve a substantial improvement in the quality of the cryo-EM density map, which is highly relevant for using cryo-EM in structure-based drug design.